SUNPHARMA.NSSUNPHARMA.NSNSE
Loading
Price to Sales: Premium ValuationElevated
Percentile Rank79
3Y CAGR+10.9%
5Y CAGR+24.6%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
+10.9%/yr
vs +5.3%/yr prior
5Y CAGR
+24.6%/yr
Recent deceleration
Acceleration
+5.6pp
Accelerating
Percentile
P79
Within normal range
vs 5Y Ago
3x
Strong expansion
Streak
1 yr
Consecutive declineElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 7.74 | -4.0% |
| 2024 | 8.06 | +50.0% |
| 2023 | 5.37 | -5.3% |
| 2022 | 5.68 | +32.6% |
| 2021 | 4.28 | +66.3% |
| 2020 | 2.57 | -34.9% |
| 2019 | 3.95 | -14.3% |
| 2018 | 4.61 | -12.7% |
| 2017 | 5.28 | -24.8% |
| 2016 | 7.02 | - |